Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein - PubMed (original) (raw)

Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein

C Hadjiagapiou et al. Nucleic Acids Res. 1994.

Free PMC article

Abstract

Mammalian small intestinal apolipoprotein B (apo B) mRNA undergoes posttranscriptional cytidine deamination with the production of an in frame stop codon and the translation of apo B48. We have isolated a cDNA from human jejunum which mediates in vitro editing of a synthetic apo B RNA template upon complementation with chicken intestinal S100 extracts. The cDNA specifies a 236 residue protein which is 69% identical to the apo B mRNA editing protein (REPR) cloned from rat small intestine [Teng, B., Burant, C. F. and Davidson, N. O. (1993) Science 260, 1816-1819] and which, by analogy, is referred to as HEPR. HEPR does not contain the carboxyl-terminus leucine zipper motif identified in REPR but contains consensus phosphorylation sites as well as the conserved histidine and both cysteine residues identified as a Zn2+ binding motif in other cytidine deaminases. The distribution of HEPR mRNA was predominantly confined to the adult small intestine with lower levels detectable by reverse-transcription polymerase chain reaction amplification in the stomach, colon and testis. These differences in the structure and distribution of the human as compared to the rat apo B mRNA editing protein suggest an important evolutionary adaptation in the mechanisms restricting apo B48 production to the small intestine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1204-10 - PubMed
    1. J Biol Chem. 1993 Oct 5;268(28):20709-12 - PubMed
    1. J Lipid Res. 1994 Feb;35(2):340-50 - PubMed
    1. J Biol Chem. 1993 Feb 5;268(4):2288-91 - PubMed
    1. Cell. 1987 Sep 11;50(6):831-40 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources